Interleukin-1,, interleukin-2, tumour necrosis factor a, and the interferons, alfa and gamma, were measured concurrently in synovial fluid samples from 68 patients with rheumatic diseases. Mean interleukin-1r concentrations (130.3 (SD 22) pg/mI) were higher in synovial fluids from patients with rheumatoid arthritis (RA) than in those from patients with osteoarthritis (27-8 (4.5) pg/ml), while measurements in synovial fluids from patients with seronegative spondarthritis were intermediate (72-7 (32) pg/ml). Interleukin-2 and tumour necrosis factor a concentrations were lower in the inflammatory arthropathies (RA: 4-5 (0.6) U/mI, 0.39 (0.04) ng/ml; seronegative spondarthritis: 3-1 (0.3) U/ml, 0-33 (0-03) ng/ml respectively) than those in patients with osteoarthritis (5-2 (0.6) U/mI; 0.05 (0.04) ng/ml). Interleukin-2 and tumour necrosis factor a concentrations correlated in all groups (r=0-7), as did the interferons alfa and gamma (r=0-7). There was no relation between interleukin-l6 and either interleukin-2 or tumour necrosis factor a, or between the interferons and any other cytokine. Several distinct cytokine patterns were noted. Synovial fluids from two non-arthritic subjects were also examined: interleukin-l,B concentrations were low, but concentrations of the other cytokines were higher than those seen in most arthritic fluids.
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Inducible peptide cytokines associated with host defence, inflammation, and tissue repair have potential pathogenic activities which are particularly relevant to the rheumatic diseases.
Interleukin-lfi (IL-1,B), interleukin-2 (IL-2), tumour necrosis factor a (TNFa), interferon alfa, and interferon gamma are among the many cytokines that can act alone or in synergy as mediators of tissue damage or chronic inflammation and which have been implicated in the pathogenesis of arthritis. ' Interleukin-l and TNFa are able to act locally to induce bone and cartilage resorption2'
-a central feature of joint disease, and TNFa is also able to accelerate proteoglycan degradation.5 IL-l, and TNFa have many in vitro activities in common7-9-each can induce the production of the other as well as that of other cytokines,'0 11 and IL-13 can also induce IL-l1 gene expression. All cytokine measurements were performed with duplicates of each sample.
Interleukin-lB was measured by amplified enzyme linked immunosorbent assay (ELISA; Cistron, New Jersey, USA). Plates precoated with monoclonal antibody to human IL-1,B were incubated with 100 pl synovial fluid (two hours, 37°C), followed by further incubations with polyclonal rabbit anti-IL-1 (two hours, 37°C) and goat antirabbit IgG conjugated to horseradish peroxidase (30 minutes, room temperature). Excess reactants were removed by washing three times between each step with phosphate buffer (0-01 M, pH 7T4) containing 1% bovine serum albumin. Addition of enzyme substrate (o-phenylenediamine; 30 minutes, room temperature) produced a chromogenic product, whose absorption was measured at 490 nm. Assay sensitivity was 20 pg/ml. Between and within batch variability (coefficient of variation), which was dependent on concentration, was not greater than 10% and 7% respectively (Cistron, New Jersey, USA). Interleukin-2, TNFa, interferons alfa and gamma were measured by radioimmunoassay (IRE-Medgenix, Fleurus, Belgium). Synovial fluid samples were preincubated with polyclonal rabbit antiserum to the relevant antigens (18 hours), followed by incubation with radiolabelled antigen (four hours) and antibodies to rabbit IgG suspended in a buffer containing polyethylene glycol, cellulose, and Tween 20 to aid precipitation (20 minutes). Incubations were performed at room temperature for IL-2, TNFa, and interferon alfa and at 4°C for interferon gamma. Bound antigen was separated from free reactants by centrifugation (2400 rpm, 15 minutes, 10°C). Sensitivity for each assay was 1 U/ml for IL-2, 0-1 ng/ml TNFa, 8-2 U/ml interferon alfa, and 2 U/ml for interferon gamma. Between and within batch variability (coefficient of variation) for all four assays was dependent on concentration and not greater than 12% and 8% respectively (IRE-Medgenix, Fleurus, Belgium).
C REACTIVE PROTEIN MEASUREMENT Serum C reactive protein was measured by immunoturbidometry using the COBAS Mira (Roche Products, Welwyn, Herts). Antiserum and calibrant were obtained from Atlantic Antibodies, Westbrook, Maine, USA. Between assay variability was 4-2%.
STATISTICAL ANALYSIS Group differences were examined by MannWhitney U test and correlations by Spearman's rank correlation coefficient.
Results Table 1 gives details of the patients studied. All had significant effusions in one or both knees requiring aspiration of fluid at the time of the study. Large variations were seen in the volume of fluid removed from the knees of different patients, in individual patients on different occasions, and in effusions from both knees of the same patients.
Synovial fluid (10 ml) was aspirated from the knee joint of subject 1 and 3-5 mi from the other control, subject 2. Table 2 shows the mean and standard deviation of cytokine concentrations in patients classified 4 5), and 72-7 (32) pglml respectively. Measurements in the group with RA were significantly higher than those i1 the other two groups (p<0 001). Table 8 shows that cytokine concentrations were similar in both subjects. Interleukin-l1 was at the lowest detection limit of the assay (20 pg/ml); concentrations of all other cytokines measured were higher than those seen in most samples from diseased joints.
CYTOKINE CONCENTRATIONS IN SYNOVIAL FLUIDS FROM DIFFERENT DIAGNOSTIC GROUPS

CORRELATIONS BETWEEN CYTOKINES
A positive correlation was apparent in all groups between IL-2 and TNFa (r=0-7) and the interferons alfa and gamma (r=0 7) (figs 4 and 5). No correlation was found between IL-1j and either IL-2 or TNFa or between the interferons and any other cytokine.
C REACTIVE PROTEIN CONCENTRATION C reactive protein concentrations in patient 11 (table 5) were significantly higher than normal (<8 mg/ml), indicating inflammation. Figure 4 Correlation between interleukin-2 (IL-2) and tumour necrosi synovialfluidsfrom all three diagnostic groups (n= 102). Spearman's ra coeffwcient r=0-7; p<0-001. ,0-5 (0-04), and 0-33
We found lower concentrations of IL-2 in itly higher than those patients with the inflammatory arthropathies than in those with non-inflammatory arthritides, as previously reported.' It has been suggested that complex formation between IL-2 and soluble IL-2 receptor accounts for the low concentrations of IL-2 and down regulation of IL-2 dependent responses seen in RA, and positive correlations between IL-1,6 and both IL-2 and soluble IL-2 receptor have been reported. 26 We were unable to find a correlation between IL-13 and IL-2 in 57 fluids from a similar patient group, however. Tumour necrosis factor concentrations, which were lower in the inflammatory arthropathies than in osteoarthritis, correlated with IL-2 measurements, and this is consistent with evidence of IL-2 stimulated production of this cytokine.27 Many stimuli induce both IL-1l6 and TNFa and thus it was interesting that we found no correlation between these cytokines in the synovial fluids examined or between the concentrations of these cytokines and the number of cells found in the fluids. Our observations ofincreased TNFa in osteoarthritis may reflect the participation of this cytokine in cartilage resorption and inhibition of proteoglycan synthesis, and TNFa concentrations have been related to disease duration in osteoarthritis.28 19284.8
The interferons alfa and gamma are thought to initiate the production of both pro-and antiinflammatory mediators through selective B cell tsfactor a (TNFa) in activation. leukin-2, TNFa, and interferon alfa and gamma concentrations were considerably higher in fluids from healthy subjects than in those from most patients and were comparable only with measurements obtained in one RA fluid (table 3) . Although these results are intriguing, they are difficult to substantiate or interpret. The amount of fluid in most normal knee joints is insufficient to aspirate enough to assay. These subjects may be abnormal, though it is noteworthy that they had relatively high concentrations of many cytokines but no joint damage. Measurement of these five cytokines concurrently in fluids from healthy subjects has not previously been reported as far as we know.
Great variation was seen in the patterns of cytokine concentration between different patients, particularly in the group with RA, although, interestingly, we did not measure any RA fluids in which all cytokines were very high. The fluid containing the highest measured amount of IL-13 (970 pg/ml) contained only moderate amounts of other cytokines (table 3) . The apparently independent nature of IL-1j was reflected in the fluids from healthy subjects as well as in many patient fluids, and in effusions from both knees of the same patient. For example, patients 8 (table 7) results were more variable. Samples from two patients in the group with RA (table 5) both showed corresponding increases in all cytokines. In patient 11 these corresponded with an increase in inflammation, as indicated by an increase of serum C reactive protein, and a worsening of clinical indices.
In some circumstances cytokine concentrations may reflect inflammatory disease activity. Little is known about the dynamics of synovial fluid and the exchange of molecules with the circulatory system. Because of the many and varied interactions of these five cytokines the relative proportions of each in synovial fluid are likely to be more important in the disease process and in predicting outcome than their presence in itself. Our continuing studies will therefore include an attempt to correlate these patterns with clinical indices and radiological changes measured over several years. 
